Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Bexarotene (LGD1069) is a retinoid analogue that is used to treat the skin manifestations of cutaneous T cell lymphoma (CTCL).
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
10 mg | In stock | $ 30.00 | |
25 mg | In stock | $ 44.00 | |
50 mg | In stock | $ 62.00 | |
100 mg | In stock | $ 91.00 | |
200 mg | In stock | $ 123.00 | |
500 mg | In stock | $ 261.00 | |
1 mL * 10 mM (in DMSO) | In stock | $ 39.00 |
Description | Bexarotene (LGD1069) is a retinoid analogue that is used to treat the skin manifestations of cutaneous T cell lymphoma (CTCL). |
Kinase Assay | Biacore studies: Competition assays are performed on a Biacore S51. A Series S Sensor chip CM5 is derivatized for immobilization of a PentaHis antibody for capture of the His-tagged p53. The level of capture is ~ 200 response units (1 response unit corresponds to 1 pg of protein per mm 2). The concentration of MDM2 protein is kept constant at 300 nM. Test compounds are dissolved in DMSO at 10 mM and further diluted to make a concentration series of inhibitor in each MDM2 test sample. The assays are run at 25 °C in running buffer (10 mM Hepes, 0.15 M NaCl, 2% DMSO). MDM2-p53 binding in the presence of inhibitor is calculated as a percentage of binding in the absence of inhibitor and IC50 is calculated using Microsoft Excel |
Synonyms | Ro 26-4455, Targretin, LGD1069 |
Molecular Weight | 348.48 |
Formula | C24H28O2 |
CAS No. | 153559-49-0 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 34.9 mg/mL (100 mM)
Ethanol: 7 mg/mL (20 mM)), Heating is recommended.
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Bexarotene 153559-49-0 Autophagy Metabolism Retinoid Receptor Ro 26-4455 cutaneous Targretin lymphoma selective,?retinoid inhibit Retinoic acid receptors antineoplastic LGD 1069 LGD-1069 T-cell LGD1069 RAR/RXR Inhibitor anti-cancer Retinoid X receptors RXR inhibitor